Find out where the venture money has been flowing in our new report on biopharma investment trends, free to download now.
Though current vaccines show efficacy, work on next-generation iterations against the South Africa variant is under way.
It's official: dramatic share price jumps in response to clinical data have become more common.
Mirati Therapeutics nearly stole the show at Asco despite not actually presenting – a fact that illustrates how low on meaningful data this year's conference was.
The biggest-ever healthcare VC round has reshaped the biotech venture landscape.